Dow Up 0.35% Nasdaq Down 0.02%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
12.31 Down 0.53(4.13%) 4:00PM EDT
Prev Close:12.84
Open:12.74
Bid:12.00 x 500
Ask:13.29 x 100
1y Target Est:27.50
Beta:2.01
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:12.16 - 12.74
52wk Range:5.70 - 19.25
Volume:343,647
Avg Vol (3m):739,286
Market Cap:417.03M
P/E (ttm):N/A
EPS (ttm):-1.34
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
VNDADown 4.13%417.03M
AZNUp 0.68%89.67B
LLYDown 0.24%66.46B
JNJUp 0.24%291.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.60
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-2.00
Quarterly EPS Est (Sep-14) :-0.39
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Vanda Pharmaceuticals Inc., a biopharmaceutical company, is engaged in the development and commercialization of pharmaceutical products. Its product portfolio includes HETLIOZ, a product for the treatment of Non-24-Hour Sleep-Wake Disorder; Fanapt... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback